Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 6—June 2011
Dispatch

Invasive Streptococcus pneumoniae in Children, Malawi, 2004–2006

Jennifer E. CornickComments to Author , Dean B. Everett, Caroline Broughton, Brigitte B. Denis, Daniel L. Banda, Enitan D. Carrol, and Christopher M. Parry
Author affiliations: Author affiliations: Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi (J.E. Cornick, D.B. Everett, B.B. Denis, D.L. Banda, E.D. Carrol); University of Liverpool, Liverpool, UK (J.E. Cornick, D.B. Everett, C. Broughton, E.D. Carrol, C.M. Parry); University of Malawi College of Medicine, Blantyre (D.L. Banda); Angkor Hospital for Children, Siem Reap, Cambodia (C.M. Parry)

Main Article

Table 2

Antimicrobial drug susceptibilities of Streptococcus pneumoniae isolates from children at Queen Elizabeth Central Hospital, Blantyre, Malawi, 2004–2006*

Antimicrobial drug MIC, mg/L
 No. (%) isolates*
 Breakpoint values
Minimum Maximum MIC50 MIC90 GM S I R S I R
Benzyl penicillin
Meningitis breakpoints <0.016 0.500 <0.016 0.094 0.025 156 (90) – 18 (10) <0.06 – >0.12
Nonmeningitis breakpoints <0.016 0.500 <0.016 0.094 0.025 176 (100) 0 0 <2.0 4.0 >8.0
Ceftriaxone
Meningitis breakpoints <0.016 0.250 <0.016 0.064 0.025 176 (100) 0 0 <0.5 1.0 >2.0
Nonmeningitis breakpoints <0.016 0.500 <0.016 0.094 0.025 176 (100) 0 0 <1.0 2.0 >4.0
Chloramphenicol 0.380 30.000 3.000 25.000 4.660 129 (73) – 47 (27) <4.0 – >8.0

*MIC50, 50% MIC; MIC90, 90% MIC; GM, geometric mean; S, susceptible; I, intermediate; R, resistant; –, no intermediate resistance values for these antimicrobial drugs, according to Clinical and Laboratory Standards Institute definitions.

Main Article

Page created: August 03, 2011
Page updated: August 03, 2011
Page reviewed: August 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external